Insulet

YTD

ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals.

CEO

Ashley A. McEvoy

CEOAshley A. McEvoy

Employees

5,400

Employees5,400

Headquarters

Acton, Massachusetts

HeadquartersActon, Massachusetts

Founded

2000

Founded2000

Employees

5,400

Employees5,400

PODD Key Statistics

Market cap

9.81B

Market cap9.81B

Price-Earnings ratio

29.24

Price-Earnings ratio29.24

Dividend yield

—

Dividend yield—

Average volume

1.86M

Average volume1.86M

High today

$147.39

High today$147.39

Low today

$139.27

Low today$139.27

Open price

$147.39

Open price$147.39

Volume

929.92K

Volume929.92K

52 Week high

$354.88

52 Week high$354.88

52 Week low

$126.40

52 Week low$126.40

Stock Snapshot

The current Insulet(PODD) stock price is $141.50, with a market capitalization of 9.81B. The stock trades at a price-to-earnings (P/E) ratio of 29.24.

On 2026-09-08, Insulet(PODD) stock traded between a low of $139.27 and a high of $147.39. Shares are currently priced at $141.50, which is +1.6% above the low and -4.0% below the high.

The Insulet(PODD)'s current trading volume is 929.92K, compared to an average daily volume of 1.86M.

During the past year, Insulet(PODD) stock moved between $126.40 at its lowest and $354.88 at its peak.

PODD News

Simply Wall St 2d

Should Insulet’s Strong Quarter but Cautious Outlook Require Action From Insulet Investors?

In the past quarter, Insulet reported a strong second-quarter update, beating earnings and revenue estimates on solid Omnipod demand while pairing this with mor...

Simply Wall St 6d

Insulet, Why Is It Back In The Spotlight?

Insulet (PODD) is back in focus after a federal securities class action lawsuit alleged the company misled investors about its manufacturing controls, following...

Analyst ratings

57%

of 28 ratings

Buy

57.1%

Hold

42.9%

Sell

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.